These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 26795692)

  • 1. Alternatives to antibiotics-a pipeline portfolio review.
    Czaplewski L; Bax R; Clokie M; Dawson M; Fairhead H; Fischetti VA; Foster S; Gilmore BF; Hancock RE; Harper D; Henderson IR; Hilpert K; Jones BV; Kadioglu A; Knowles D; Ólafsdóttir S; Payne D; Projan S; Shaunak S; Silverman J; Thomas CM; Trust TJ; Warn P; Rex JH
    Lancet Infect Dis; 2016 Feb; 16(2):239-51. PubMed ID: 26795692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines and antibiotic resistance.
    Mishra RP; Oviedo-Orta E; Prachi P; Rappuoli R; Bagnoli F
    Curr Opin Microbiol; 2012 Oct; 15(5):596-602. PubMed ID: 22981392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials.
    Karpiuk I; Tyski S
    Przegl Epidemiol; 2015; 69(4):723-9, 865-70. PubMed ID: 27139351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technologies to address antimicrobial resistance.
    Baker SJ; Payne DJ; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12887-12895. PubMed ID: 30559181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals.
    Allen HK; Levine UY; Looft T; Bandrick M; Casey TA
    Trends Microbiol; 2013 Mar; 21(3):114-9. PubMed ID: 23473629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances in antibiotic development and discovery.
    Alekshun MN
    Expert Opin Investig Drugs; 2005 Feb; 14(2):117-34. PubMed ID: 15757391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
    Martínez JL
    Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing therapeutic challenges through multi-resistant bacteria in the hospital].
    Miethke T
    Zentralbl Chir; 2012 Jun; 137(3):279-83. PubMed ID: 21360428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.
    Hoelzer K; Bielke L; Blake DP; Cox E; Cutting SM; Devriendt B; Erlacher-Vindel E; Goossens E; Karaca K; Lemiere S; Metzner M; Raicek M; Collell Suriñach M; Wong NM; Gay C; Van Immerseel F
    Vet Res; 2018 Jul; 49(1):70. PubMed ID: 30060759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antibiotics: are we still in the pre-post-antibiotic era?
    Draenert R; Seybold U; Grützner E; Bogner JR
    Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections.
    Simões NG; Bettencourt AF; Monge N; Ribeiro IAC
    Mini Rev Med Chem; 2017; 17(14):1364-1376. PubMed ID: 27629996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial armamentarium: evaluating current and future treatment options.
    Bosso JA
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):55S-62S. PubMed ID: 16178676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches are needed to develop tomorrow's antibacterial therapies.
    Spellberg B; Bartlett J; Wunderink R; Gilbert DN
    Am J Respir Crit Care Med; 2015 Jan; 191(2):135-40. PubMed ID: 25590154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Looking for the new preparations for antibacterial therapy. I. New antibiotics and chemotherapeutics on the market].
    Karpiuk I; Tyski S
    Przegl Epidemiol; 2012; 66(4):567-73. PubMed ID: 23484382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance acquisition via the bacterial SOS response: the inducive role of antibiotics].
    Da Re S; Ploy MC
    Med Sci (Paris); 2012 Feb; 28(2):179-84. PubMed ID: 22377306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which alternatives are at our disposal in the anti-infectious therapeutics face to multi-drug resistant bacteria?].
    Bourlioux P
    Ann Pharm Fr; 2013 May; 71(3):150-8. PubMed ID: 23622693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.